Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Marcoux

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The European Respiratory Journal|March 1, 2023
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based studyYet H Khor, Max Schulte, Kerri A Johannson, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
Chest|February 29, 2024
The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung DiseaseSabina A Guler, Daniel-Costin Marinescu, Gerard Cox, et al.
Respiratory Medicine|April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung diseaseGiulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Respiratory Medicine|December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune featuresSana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)|May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary FibrosisCathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung DiseaseFerhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
The European Respiratory Journal|March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registryNathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The European Respiratory Journal|March 1, 2023
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based studyYet H Khor, Max Schulte, Kerri A Johannson, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
Chest|February 29, 2024
The Clinical Frailty Scale for Risk Stratification in Patients With Fibrotic Interstitial Lung DiseaseSabina A Guler, Daniel-Costin Marinescu, Gerard Cox, et al.
Respiratory Medicine|April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung diseaseGiulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Annals of the American Thoracic Society|December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung DiseaseAlyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Respiratory Medicine|December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune featuresSana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)|May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary FibrosisCathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung DiseaseFerhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
The European Respiratory Journal|March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registryNathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Pageof 5